LIFECORE BIOMEDICAL, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for the quarter ending 2021-02-28 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for the quarter ending 2020-11-29 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for the quarter ending 2020-08-30 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for the quarter ending 2020-02-23 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for fiscal 2017 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for fiscal 2016 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for fiscal 2015 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. treasury stock, shares, acquired for fiscal 2014 was 0.00 shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2021-02-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | |
| 2020-11-29 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | |
| 2020-08-30 | 0.00 shares 10-Q · filed 2020-10-07 | |
| 2020-02-23 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | |
| 2019-11-24 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | |
| 2019-08-25 | 0.00 shares 10-Q · filed 2019-10-03 | |
| 2019-02-24 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | 0.00 shares derived: sum of 4 quarters · filed 2019-04-04 |
| 2018-11-25 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | 0.00 shares derived: sum of 4 quarters · filed 2019-01-07 |
| 2018-08-26 | 0.00 shares 10-Q · filed 2018-10-05 | 0.00 shares derived: sum of 4 quarters · filed 2018-10-05 |
| 2018-05-27 | 0.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2018-10-05 | 0.00 shares 10-Q · filed 2018-10-05 |
| 2018-02-25 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | 0.00 shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-11-26 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | 0.00 shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-08-27 | 0.00 shares 10-Q · filed 2017-09-28 | |
| 2017-05-28 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | 0.00 shares 10-K · filed 2018-08-09 |
| 2017-02-26 | 0.00 shares 10-Q · filed 2017-04-07 | |
| 2016-08-28 | 0.00 shares 10-Q · filed 2016-09-29 | 0.00 shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-05-29 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | 0.00 shares 10-K · filed 2018-08-09 |
| 2016-02-28 | 0.00 shares 10-Q · filed 2016-03-30 | |
| 2015-11-29 | 0.00 shares 10-Q · filed 2016-01-07 | |
| 2015-05-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | 0.00 shares 10-K/A · filed 2018-03-15 |
| 2015-03-01 | 0.00 shares 10-Q · filed 2015-04-02 | |
| 2014-05-25 | 0.00 shares 10-K · filed 2016-08-01 | |
| 2013-05-26 | 0.00 shares 10-K · filed 2015-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |